ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

No Cancer Letter For Next Two Weeks

August 30, 1991

“NCI activities at Frederick are not well integrated…. It would be wise to reorganize and consolidate.”

July 21, 1995

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

In Brief: MSK Opens Campaign On Colorectal Cancer Early Detection NIH Symposium Dedicates Cyclotron

August 28, 1987

CCOPs Extended One Year While Waiting Evaluation

May 17, 1985

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004